Afuco™ Anti-Human SLAMF7 ADCC Therapeutic Antibody (PDL241), ADCC Enhanced
Anti-SLAMF7 ADCC Enhanced Antibody (PDL241) is an ADCC enhanced antibody produced by our Afuco™ platform. PDL241 is a novel humanized monoclonal antibody to CD319, used as a therapeutic target for rheumatoid arthritis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-548CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | SLAMF7 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |